PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
09-Sep-2021 HUTCHMED and AstraZeneca Initiate SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China HUTCHMED and AstraZeneca
09-Sep-2021 ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly ProQR
09-Sep-2021 USPTO Grants ONK Therapeutics’ Foundational Patent for CISH Knockout in NK Cells for Use in Cancer Therapies ONK Therapeutics
09-Sep-2021 Nanoform technology delivers successful results for Herantis CDNF drug candidate Nanoform
09-Sep-2021 Freeline Announces Orphan Drug Designations for FLT201 for the Treatment of Gaucher Disease Freeline
09-Sep-2021 Moderna Announces Significant Advances Across Industry-Leading mRNA Portfolio at 2021 R&D Day Moderna
09-Sep-2021 Centessa Pharmaceuticals Announces Positive Topline Data from Proof-of-Concept Study of SerpinPC in Severe Hemophilia A and B Patients Not on Prophylaxis Centessa Pharmaceuticals
09-Sep-2021 Amolyt Pharma Exercises Option to License Optimized Acromegaly Drug Candidate from PeptiDream as it Continues to Build its Rare Endocrine Pipeline Amolyt Pharma
09-Sep-2021 Anticancer Bioscience Announces its First Granted US Patent for Synthetic Lethal Approach to Identifying Novel Cancer Treatments Anticancer Bioscience
08-Sep-2021 NICE backs Janssen’s Erleada®▼ (apalutamide) for Hormone-Sensitive Metastatic and Hormone-Relapsed Non-Metastatic Prostate Cancer Janssen
07-Sep-2021 HUTCHMED Highlights Clinical Data to be Presented at the Upcoming 2021 ESMO Virtual Conference HUTCHMED
06-Sep-2021 New tezepelumab data show 86% reduction in exacerbations in patients with severe asthma and comorbid nasal polyps AstraZeneca
01-Sep-2021 Bimuno surpasses 100 scientific publications landmark Clasado Biosciences
01-Sep-2021 ExeVir Announces First Patient Enrolled in Phase 1b/2 Clinical Study evaluating XVR011 as antiviral treatment of patients hospitalised for COVID-19 ExeVir
31-Aug-2021 AlzeCure’s Alzheimer’s project receives approval to start next clinical phase I study with ACD856 AlzeCure Pharma AB
27-Aug-2021 Grupo NotreDame Intermédica (GNDI) of Brazil enhances patient care and improves patient access to leading-edge medications by joining Clinerion’s global network of hospital partners on Patient Network Explorer. Clinerion Ltd.
24-Aug-2021 AWAKN LIFE SCIENCES INITIATES THE FIRST KETAMINE TREATMENT STUDY FOR GAMBLING ADDICTION LED BY PROFESSOR CELIA MORGAN Awakn Life Sciences Corp.
24-Aug-2021 BridgeHead Enables Biomedical Imaging Centre’s Enterprise Imaging Strategy For Leading Research BridgeHead Software
23-Aug-2021 Targeting the Putamen with Gene Therapy Leads to Sustained Improvements in Motor and Non-Motor Functions in Children with AADC Deficiency PTC Therapeutics, Inc.
20-Aug-2021 Clinerion patent for technology underpinning Patient Network Explorer is published. Clinerion Ltd.